ICU Medical, Inc. (NASDAQ: ICUI) reported Q2 EPS of $0.38, $0.04 better than the analyst estimate of $0.34. Revenue for the quarter came in at $78.7 million versus the consensus estimate of $74.13 million.

Guidance

GAAP diluted earnings per share is increased to a range of $1.30 to $1.50 compared to the previous range of $1.15 to $1.45. Adjusted diluted earnings per share is in the range of $1.95 to $2.15, and adjusted EBITDA range is increased to $63 million to $68 million compared to the previous range $58 million to $65 million.

For earnings history and earnings-related data on ICU Medical, Inc. (ICUI) click here.